Eurich Dennis, Schlickeiser Stephan, Ossami Saidy Ramin Raul, Uluk Deniz, Rossner Florian, Postel Maximilian, Schoening Wenzel, Oellinger Robert, Lurje Georg, Pratschke Johann, Reinke Petra, Gruen Natalie
Department of Surgery, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
J Clin Med. 2023 Oct 16;12(20):6546. doi: 10.3390/jcm12206546.
Operational tolerance as the ability to accept the liver transplant without pharmacological immunosuppression is a common phenomenon in the long-term course. However, it is currently underutilized due to a lack of simple diagnostic support and fear of rejection despite its recognized benefits. In the present work, we present a simple score based on clinical parameters to estimate the probability of tolerance.
In order to estimate the probability of tolerance, clinical parameters from 82 patients after LT who underwent weaning from the IS for various reasons at our transplant center were extracted from a prospectively organized database and analyzed retrospectively. Univariate testing as well as multivariable logistic regression analysis were performed to assess the association of clinical variables with tolerance in the real-world setting.
The most important factors associated with tolerance after multivariable logistic regression were IS monotherapy, male sex, history of hepatocellular carcinoma pretransplant, time since LT, and lack of rejection. These five predictors were retained in an approximate model that could be presented as a simple scoring system to estimate the clinical probability of tolerance or IS dispensability with good predictive performance (AUC = 0.89).
In parallel with the existence of a tremendous need for further research on tolerance mechanisms, the presented score, after validation in a larger collective preferably in a multicenter setting, could be easily and safely applied in the real world and already now address all three levels of prevention in LT patients over the long-term course.
作为在无药物免疫抑制情况下接受肝移植的能力,手术耐受性是长期病程中的常见现象。然而,尽管其益处已得到认可,但由于缺乏简单的诊断支持以及对排斥反应的担忧,目前该现象未得到充分利用。在本研究中,我们提出了一种基于临床参数的简单评分方法来估计耐受性的概率。
为了估计耐受性的概率,我们从一个前瞻性组织的数据库中提取了在我们移植中心因各种原因停止免疫抑制(IS)的82例肝移植术后患者的临床参数,并进行回顾性分析。进行单变量测试以及多变量逻辑回归分析,以评估临床变量与现实环境中耐受性的关联。
多变量逻辑回归后与耐受性相关的最重要因素是IS单药治疗、男性、移植前肝细胞癌病史、肝移植后的时间以及无排斥反应。这五个预测因素保留在一个近似模型中,该模型可以表示为一个简单的评分系统,以估计耐受性或IS可停用性的临床概率,具有良好的预测性能(AUC = 0.89)。
在对耐受性机制仍有巨大进一步研究需求的同时,所提出的评分在更大的群体中(最好是在多中心环境中)经过验证后,可以在现实世界中轻松、安全地应用,并且现在就可以在长期病程中解决肝移植患者预防的所有三个层面的问题。